IMNM

Immunome, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$21.84

Market Cap

$1.92B

Beta

2.14

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-23.23%

EPS Growth (YoY)+84.03%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-10.45%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for IMNM.